Human Pancreatic Cancer Cell PANC-1 Transfection Kit

Description

In the realm of in vitro cell line research, PANC-1 stands out as a widely explored and comprehensively characterized cell line, frequently employed as a model for pancreatic ductal adenocarcinoma studies. The importance of PANC-1 in pancreatic cancer therapeutic assays cannot be overstated, as it provides a reliable and essential tool for researchers in this field. PANC-1 cell line was derived from the pancreatic duct tissue of a 56-year-old Caucasian male afflicted with epithelioid carcinoma, thereby making it an ideal in vitro model for pancreatic cancer research. PANC-1 cells are sensitive to L-asparaginase, an enzyme that limits cell growth. Additionally, PANC-1 cells are commonly used as a non-endocrine pancreatic cancer model for tumorigenicity studies. Moreover, the PANC abbreviation refers to the human pancreas, the organ where pancreatic cancer is typically found. Notably, PANC-1 cells also serve as excellent transfection hosts for introducing exogenous molecules into the cell. CD BioSciences offers a cutting-edge cationic liposome formulation specifically optimized for transfecting PANC-1 cells, which significantly increases the efficacy of transfection. This transfection kit is pre-optimized for the intracellular delivery of plasmid DNA, siRNA, and mRNA molecules into PANC-1 non-endocrine pancreatic cancer cell line, thus providing a robust and reliable tool for life sciences laboratory research studies.